HBIO
Harvard Bioscience Inc
Price:  
1.31 
USD
Volume:  
326,966.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO Relative Valuation

-840.8%
Upside

As of 2025-02-13, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (9.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.31 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -840.8%.

The range of the Relative Valuation is (9.38) - (10.06) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.7x - 33.4x 31.6x
Forward P/E multiples 26.2x - 30.8x 27.9x
Fair Price (9.38) - (10.06) (9.70)
Upside -815.8% - -868.1% -840.8%
1.31 USD
Stock Price
(9.70) USD
Fair Price

HBIO Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -4.41
2025-02-06 -4.53
2025-02-05 -5.08
2025-02-04 -5.12
2025-02-03 -5.05
2025-01-31 -5.24
2025-01-30 -5.42
2025-01-29 -5.36
2025-01-28 -5.24
2025-01-27 -5.51
2025-01-24 -5.33
2025-01-23 -5.64
2025-01-22 -5.97
2025-01-21 -5.97
2025-01-17 -5.91
2025-01-16 -5.88
2025-01-15 -6.06
2025-01-14 -6.19
2025-01-13 -6.06
2025-01-10 -5.82
2025-01-08 -6.59
2025-01-07 -6.59
2025-01-06 -6.71
2025-01-03 -6.55
2025-01-02 -6.22
2024-12-31 -6.46
2024-12-30 -6.19
2024-12-27 -6.06
2024-12-26 -6.43
2024-12-24 -6.37
2024-12-23 -6.43
2024-12-20 -6.46
2024-12-19 -6.43
2024-12-18 -6.22
2024-12-17 -6.65
2024-12-16 -6.55
2024-12-13 -6.62
2024-12-12 -6.86
2024-12-11 -7.11
2024-12-10 -7.17
2024-12-09 -7.14
2024-12-06 -6.92
2024-12-05 -6.55
2024-12-04 -6.92
2024-12-03 -6.86
2024-12-02 -6.74
2024-11-29 -6.74
2024-11-27 -6.74
2024-11-26 -6.71
2024-11-25 -6.86